Insights On Partnering
-
Navigating Autoimmune Disease A Playbook For Cell And Gene Therapies
9/3/2025
By integrating site readiness, patient engagement, and data-driven decision-making, the cell and gene therapies (CAGT) field is advancing toward therapies that not only control disease but transform lives.
-
Elevating Patient Centricity In Clinical Trials
2/17/2025
How can the integration of patient perspectives throughout the clinical trial process enhance engagement and outcomes?
-
Global Vaccine Trials Case Study
5/22/2024
Explore targeted strategies for tackling the complexities of international payments and providing comprehensive participant support in global vaccine trials.
-
Key Criteria For Choosing The Right Phase 1 CRO
6/2/2025
What steps can you take to select the best CRO partner for your Phase 1 clinical trial?
-
Overcoming Unexpected Obstacles In A Phase 1 Study
1/29/2025
Discover how the implementation of mobile vision clinics (MVCs) was used to enhance efficiency in a Phase 1 clinical trial.
-
Advancing Oncology Innovation With Adaptive Trial Designs
8/12/2025
When a biopharmaceutical company developing a novel therapy for solid tumor cancers became concerned with rapid over-enrollment from within a single region, they employed a CRO for assistance.
-
Insights From Facilitating Over A Billion Dollars In Vendor Contracts
7/1/2025
By transforming vendor selection from a manual task into a data-driven, strategic process, sponsors can build stronger, more effective clinical trial teams.
-
Why Asia Should Be Your Next Trial Destination
10/17/2025
Many U.S. oncology sponsors are expanding their late-phase trials into Asia to secure access to rich patient pools, leverage efficient regulatory pathways, and save time and money in the clinic.
-
EHR-To-EDC: Choosing The Right Solution For Clinical Trials
12/13/2024
Here we highlight key advantages of EHR-to-EDC eSource, such as cost-effectiveness and improved site satisfaction.
-
2025 Clinical Trial Payment Tax Implications Explained
10/8/2025
Flat-rate clinical trial payments are often taxable in the U.S., while reimbursements are not. Unclear tax rules can impact participant trust, site communication, and trial retention.